Pipeline

Our lead product candidate, AVB-500, is an ultra-high affinity decoy protein that starves the GAS6/AXL signaling pathway.

AVB-500 suppresses migration and invasion in cancer and fibrosis by capturing circulating and bound GAS6. In both ovarian cancer and IgA nephropathy, increased GAS6 expression has been demonstrated.